Anti-IgG Nanobodies Patent Granted to Max-Planck
Summary
USPTO granted patent US12600799B2 to Max-Planck-Gesellschaft on April 14, 2026 for novel anti-IgG nanobodies directed against rabbit or mouse IgG. The patent contains 11 claims classified under CPC C07K 16/42. The invention also covers methods for producing and using said nanobodies.
What changed
The USPTO granted patent US12600799B2 to Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. for novel anti-IgG nanobodies, specifically those directed against rabbit or mouse IgG. The patent includes 11 claims and covers methods for producing and using the nanobodies.
For entities developing nanobody technologies or antibody-related products, this granted patent establishes new intellectual property rights that may affect freedom-to-operate considerations in the nanobody research and development space.
What to do next
- Monitor for updates
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Anti-IgG nanobodies
Grant US12600799B2 Kind: B2 Apr 14, 2026
Assignee
MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
Inventors
Dirk Görlich, Tino Pleiner
Abstract
The present invention relates to novel anti-IgG nanobodies, particularly nanobodies directed against rabbit or mouse IgG. Further, the invention relates to the use of said nanobodies and methods for producing them.
CPC Classifications
C07K 16/42 C07K 2317/22 C07K 2317/33 C07K 2317/569 C07K 2317/92
Filing Date
2018-10-11
Application No.
16754847
Claims
11
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.